Virginia Retirement Systems’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $750K | Buy |
83,704
+27,000
| +48% | +$242K | 0.01% | 652 |
|
|
2025
Q1 | $425K | Buy |
+56,704
| New | +$425K | ﹤0.01% | 798 |
|
|
2023
Q3 | $333K | Sell |
47,100
-33,500
| -42% | -$237K | ﹤0.01% | 789 |
|
|
2023
Q2 | $567K | Buy |
80,600
+64,900
| +413% | +$457K | 0.01% | 695 |
|
|
2023
Q1 | $131K | Buy |
15,700
+4,500
| +40% | +$37.5K | ﹤0.01% | 990 |
|
|
2022
Q4 | $129K | Buy |
+11,200
| New | +$129K | ﹤0.01% | 1083 |
|
|
2021
Q1 | – | Sell |
-10,500
| Closed | -$78K | – | 1105 |
|
|
2020
Q4 | $78K | Hold |
10,500
| – | – | ﹤0.01% | 1090 |
|
|
2020
Q3 | $36K | Sell |
10,500
-4,400
| -30% | -$15.1K | ﹤0.01% | 1071 |
|
|
2020
Q2 | $71K | Buy |
+14,900
| New | +$71K | ﹤0.01% | 1071 |
|
|
2020
Q1 | – | Sell |
-16,900
| Closed | -$58K | – | 1091 |
|
|
2019
Q4 | $58K | Buy |
+16,900
| New | +$58K | ﹤0.01% | 1118 |
|